Please login to the form below

Not currently logged in
Email:
Password:

New accounts: November - PR & Med Ed

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2006 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

Cephalon

Targretin

Oncology

LeapFrog Medical

MSD

Univads website

N/A

LeapFrog Medical

Novo Nordisk

Healthspan range

Vitamins and minerals

Spink Consumer Relations

Reckitt Benckiser (global)

Nurofen

Pain

Virgo Health PR

Roche Products UK

Bondronat

Endocrine

Just::

Solvay

Creon

Cystic fibrosis

LeapFrog Medical

Takeda Europe

Actos

Type II diabetes

The Remedy, Fleishman-Hillard

Takeda Europe

Blopress

Hypertension

The Remedy, Fleishman-Hillard

Takeda Europe

Prostap SR

Prostate cancer

The Remedy, Fleishman-Hillard

Takeda Europe

Rozerem

Insomnia

The Remedy, Fleishman-Hillard

Takeda Europe

International medical meetings

N/A

The Remedy, Fleishman-Hillard

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...